Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns
15 juli 2015 uppdaterad av: Memorial Sloan Kettering Cancer Center
Melanoma Survivors: Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns
The purpose of this study is to examine the health behaviors of melanoma survivors.
We want to know about their thoughts and concerns.
Melanoma is a type of skin cancer.
The number of people being diagnosed with melanoma is growing.
Many people who are diagnosed with melanoma are young.
Little research has been done to find out how melanoma survivors feel years after they have been treated.
Studieöversikt
Status
Avslutad
Betingelser
Intervention / Behandling
Detaljerad beskrivning
The rapidly rising incidence and mortality rates of melanoma, the most fatal form of skin cancer, are among the greatest increases of all preventable cancers over the past decade.
However, because of recent advances in early detection, secondary prevention efforts, and treatment, the number of melanoma survivors is increasing.
Little research has been conducted on melanoma survivors and important opportunities exist for research in this understudied population.
Understanding recurrence and second primary cancer risk, cognitive characteristics, behaviors, surveillance patterns, economic sequelae, and family issues of melanoma survivors is imperative from a public health standpoint to promote the health and well-being of this cohort.
The objectives of this study are to: 1) conduct focus groups to enhance our understanding of the behaviors of melanoma survivors, and 2) conduct a pilot survey study based on the results of the focus groups to further describe the behavioral and psychosocial issues in melanoma survivors.
This will be among the first studies that explores behavioral and psychosocial issues in melanoma survivors.
The study findings will inform a large-scale melanoma survivorship grant proposal to the National Cancer Institute or other federal/private sources of funding.
Studietyp
Observationell
Inskrivning (Faktisk)
160
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
New York
-
New York, New York, Förenta staterna, 10065
- Memorial Sloan-Kettering Cancer Center 1275 York Avenue
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
18 år och äldre (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Allt
Testmetod
Icke-sannolikhetsprov
Studera befolkning
Eligible melanoma survivors will be initially identified and screened using the Melanoma DMT Database.
We will select a random sample from the database.
Beskrivning
Inclusion Criteria:
For the focus group recruitment (Specific Aim 1) - Patients with melanoma (invasive primary cutaneous melanoma, stages 1-III), who have been treated at MSKCC from 1996-2005
For the survey group recruitment (Specific Aim 2):
patients with melanoma (invasive primary cutaneous melanoma, stages 1-III), who have been treated at MSKCC from 2001-2011• Ability to sign informed consent which indicates the psychosocial, behavioral, epidemiological nature of this study
• Age ≥ or = to 18 years and fluent in the English language
Exclusion Criteria:
Patients with intraepithelial (in situ) melanoma
- Patients with stage IV melanoma
- Patients with nodal or visceral melanoma without a documented primary lesion
- Patients with prior malignancies For the focus group recruitment (Specific Aim 1): (patients treated at MSKCC from 1996-2005) who have a diagnosis >10 years ago from treatment. For the survey group recruitment (Specific Aim 2): patients treated at MSKCC from 2001-2011)who have a diagnosis >10 years ago from treatment.
- Patients with a recent diagnosis of melanoma, <12 months
- Patients who are one year or more post diagnosis and are still receiving treatment for their melanoma
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
|---|---|
|
Specific Aim 1- Focus Group
Conduct focus groups in melanoma survivors to enhance the understanding of the behavioral aspects of:
|
Conduct focus groups in melanoma survivors to enhance the understanding of the behavioral aspects of:
|
|
Specific Aim 2- Survey Study
A separate random sample of melanoma survivors will complete the pilot questionnaire.
To enhance completion rates, survey instruments will be developed to be both self-administered and interviewer-administered.
The survey will include questions from existing surveys, regarding demographics, sun sensitivity, eye and hair color, color of untanned skin, sun exposure, skin selfexamination, sun protection practices and frequency of sunburns, psychosocial/cognitive factors: skin cancer knowledge, skin awareness, cancer worry, perceived risk of recurrence, cancer risk and screening behaviors, and access to health care and insurance.
|
History of sun exposure Medical factors Affect, cognition, and quality of life Behavioral adoption Demographics Phenotypic factors Economic/healthcare factors
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
This pilot study will provide baseline data to enhance our understanding of the behaviors of melanoma survivors.
Tidsram: 2 hours
|
2 hours
|
Sekundära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Conduct a pilot survey study of melanoma survivors to describe the behavioral and psychosocial issues in melanoma survivors. Results from the survey will enable us to obtain preliminary data in order to conduct a larger scale study.
Tidsram: half an hour
|
half an hour
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Utredare
- Huvudutredare: Susan Oliveria, ScD, MPH, Memorial Sloan Kettering Cancer Center
Publikationer och användbara länkar
Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.
Användbara länkar
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart
1 oktober 2006
Primärt slutförande (Faktisk)
1 juli 2015
Avslutad studie (Faktisk)
1 juli 2015
Studieregistreringsdatum
Först inskickad
15 augusti 2007
Först inskickad som uppfyllde QC-kriterierna
15 augusti 2007
Första postat (Uppskatta)
17 augusti 2007
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
16 juli 2015
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
15 juli 2015
Senast verifierad
1 juli 2015
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 06-128
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .